Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.5325
-0.0026 (-0.49%)
At close: Nov 3, 2025, 4:00 PM EST
0.5371
+0.0046 (0.86%)
After-hours: Nov 3, 2025, 5:09 PM EST
Impact BioMedical Market Cap
Impact BioMedical has a market cap or net worth of $6.46 million as of November 3, 2025. Its market cap has decreased by -61.53% in one year.
Market Cap
6.46M
Enterprise Value
28.14M
1-Year Change
-61.53%
Ranking
Category
Stock Price
$0.53
Market Cap Chart
Since the IPO on September 16, 2024, Impact BioMedical's market cap has decreased from $34.49M to $6.46M, a decrease of -81.28%. That is a compound annual growth rate of -77.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 6.52M | -60.91% |
| Dec 31, 2024 | 16.68M | -51.64% |
| Sep 16, 2024 | 34.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |